EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Systematic interrogation of CRISPR antimicrobials in Klebsiella pneumoniae reveals nuclease-, guide- and strain-dependent features influencing antimicrobial activity

Elena Vialetto iD, Solange Miele, Moran G Goren iD, Jiaqi Yu, Yanying Yu, Daphne Collias, Beatriz Beamud, Lisa Osbelt, Marta Lourenço, Till Strowig, Sylvain Brisse iD, Lars Barquist iD und 3 weitere

Nucleic Acids Research · 10.06.2024 · 52 (10) · 6079-6091

DOI: 10.1093/nar/gkae281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 25.04.2024. Verfasst von Elena Vialetto und 14 weiteren Autor:innen. Beteiligte Einrichtung: Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), 97080 Würzburg, Germany. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, CRISPR-Cas Systems, RNA, Guide, CRISPR-Cas Systems. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Joint Programming Initiative on Antimicrobial Resistance, Pfizer Foundation, Bavarian State Ministry for Science and the Arts.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR-Cas systems can be utilized as programmable-spectrum antimicrobials to combat bacterial infections. However, how CRISPR nucleases perform as antimicrobials across target sites and strains remains poorly explored. Here, we address this knowledge gap by systematically interrogating the use of CRISPR antimicrobials using multidrug-resistant and hypervirulent strains of Klebsiella pneumoniae as models. Comparing different Cas nucleases, DNA-targeting nucleases outperformed RNA-targeting nucleases based on the tested targets. Focusing on AsCas12a that exhibited robust targeting across different strains, we found that the elucidated modes of escape varied widely, restraining opportunities to enhance killing. We also encountered individual guide RNAs yielding different extents of clearance across strains, which were linked to an interplay between improper gRNA folding and strain-specific DNA repair and survival. To explore features that could improve targeting across strains, we performed a genome-wide screen in different K. pneumoniae strains that yielded guide design rules and trained an algorithm for predicting guide efficiency. Finally, we showed that Cas12a antimicrobials can be exploited to eliminate K. pneumoniae when encoded in phagemids delivered by T7-like phages. Altogether, our results highlight the importance of evaluating antimicrobial activity of CRISPR antimicrobials across relevant strains and define critical parameters for efficient CRISPR-based targeting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeCRISPR-Cas SystemsRNA, Guide, CRISPR-Cas SystemsBacterial ProteinsEndodeoxyribonucleasesKlebsiella InfectionsCRISPR-Associated ProteinsAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialClustered Regularly Interspaced Short Palindromic RepeatsGenome, BacterialGene EditingHumans

Substanzen

RNA, Guide, CRISPR-Cas SystemsBacterial ProteinsEndodeoxyribonucleasesCRISPR-Associated ProteinsAnti-Bacterial AgentsCas12a protein

Autor:innen und Institutionen

  • Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), 97080 Würzburg, Germany.
  • Institut Pasteur, Université Paris Cité, Synthetic Biology, Paris, France.
  • Faculty of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel.
  • Helmholtz Centre for Infection Research (HZI), 38124 Braunschweig, Germany.
  • German Center for Infection Research (DZIF), partner site Hannover-Braunschweig, 38124 Braunschweig, Germany.
  • Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.

ORCID-Profile: Elena Vialetto, Moran G Goren, Sylvain Brisse, Lars Barquist, Udi Qimron, David Bikard, Chase L Beisel

Förderung

  • Joint Programming Initiative on Antimicrobial Resistance
  • Pfizer Foundation
  • Bavarian State Ministry for Science and the Arts
  • European Research Council

Zitieren

APA

Vialetto, E., Miele, S., Goren, M. G., Yu, J., Yu, Y., Collias, D., Beamud, B., Osbelt, L., Lourenço, M., Strowig, T., Brisse, S., Barquist, L., Qimron, U., Bikard, D., & Beisel, C. L. (2024). Systematic interrogation of CRISPR antimicrobials in Klebsiella pneumoniae reveals nuclease-, guide- and strain-dependent features influencing antimicrobial activity. Nucleic Acids Research, 52(10), 6079-6091. https://doi.org/10.1093/nar/gkae281

Vancouver

Vialetto E, Miele S, Goren MG, Yu J, Yu Y, Collias D, et al. Systematic interrogation of CRISPR antimicrobials in Klebsiella pneumoniae reveals nuclease-, guide- and strain-dependent features influencing antimicrobial activity. Nucleic Acids Research. 2024;52(10):6079-6091. doi:10.1093/nar/gkae281

BibTeX
@article{Vialetto2024,
  author = {Vialetto, Elena and Miele, Solange and Goren, Moran G and Yu, Jiaqi and Yu, Yanying and Collias, Daphne and Beamud, Beatriz and Osbelt, Lisa and Lourenço, Marta and Strowig, Till and Brisse, Sylvain and Barquist, Lars and Qimron, Udi and Bikard, David and Beisel, Chase L},
  title = {Systematic interrogation of CRISPR antimicrobials in Klebsiella pneumoniae reveals nuclease-, guide- and strain-dependent features influencing antimicrobial activity},
  journal = {Nucleic Acids Research},
  year = {2024},
  volume = {52},
  number = {10},
  pages = {6079--6091},
  doi = {10.1093/nar/gkae281}
}
Kostenlos starten →